Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Deciphera Pharmaceuticals...

    NASDAQ: DCPH · Real-Time Price · USD
    25.59
    0.02 (0.08%)
    At close: Jun 10, 2024, 10:00 PM

    Deciphera Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 163.36M 134.04M 96.15M
    Cost of Revenue
    		 3.73M 8.77M 2.93M
    Gross Profit
    		 159.62M 125.27M 93.22M
    Operating Income
    		 -210.96M -182.72M -300.08M
    Interest Income
    		 16.45M 4.51M 113K
    Pretax Income
    		 -194.51M -178.21M -299.96M
    Net Income
    		 -194.94M -178.93M -296.84M
    Selling & General & Admin
    		 136.46M 120.17M 136.25M
    Research & Development
    		 234.12M 187.82M 257.04M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 370.58M 307.99M 393.29M
    Interest Expense
    		 n/a 4.51M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 374.31M 316.76M 396.23M
    Income Tax Expense
    		 431K 722K -3.13M
    Shares Outstanding (Basic)
    		 85.06M 75.5M 58.08M
    Shares Outstanding (Diluted)
    		 85.06M 75.5M 58.08M
    EPS (Basic)
    		 -2.29 -2.37 -5.11
    EPS (Diluted)
    		 -2.29 -2.37 -5.11
    EBITDA
    		 -208.86M -182.72M -300.08M
    EBIT
    		 -210.96M -173.7M -300.08M
    Depreciation & Amortization
    		 2.1M 2.95M 3.01M

    Add to Watchlist